Scleroderma: oral manifestations
Moniaci, D.; Rivetti, M.; Flecchia, G.; Ferrari Parabita, S.; Re, G.
Minerva Stomatologica 38(2): 295-298
1989
ISSN/ISBN: 0026-4970 PMID: 2651876 Document Number: 346452
Oral signs of sclerodermia and dental implications are described. The disease can be classified among the collagenopathies and its onset often involves dermatological signs prior to involving other organs and systems.
Document emailed within 1 workday
Related Documents
Kochetov, D.P.; Krivosheev, B.N. 1976: Scleroderma and porphyria cutanea tarda with clinical manifestations of scleroderma Vestnik Dermatologii i Venerologii 1: 64-68König, G.; O'Sullivan, C.; Luderschmidt, C.; Scherer, U.; Albrecht, J.; Fruhmann, G. 1983: Pulmonary manifestations of scleroderma Praxis und Klinik der Pneumologie 37(Suppl 1): 784-786
Cruchaud, A. 1973: Pulmonary manifestations of scleroderma Le Poumon et le Coeur 29(3): 311-318
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Karateev, A.E.; Movsiian, A.E.; Anan'eva, M.M.; Radenska-Lopovok, S.G. 2014: Clinical, endoscopic and morphological manifestations of oesophageal lesion in systemic scleroderma Klinicheskaia Meditsina 92(6): 67-74
Poirier, T.J.; Rankin, G.B. 1972: Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases American Journal of Gastroenterology 58(1): 30-44
Ziegler, V.; Haustein, U.F.; Mehlhorn, J.; Münzberger, H.; Rennau, H. 1986: Quartz-induced scleroderma. Scleroderma-like syndrome or true progressive scleroderma? Dermatologische Monatschrift 172(2): 86-90
Behr, J.; Adelmann-Grill, B.C.; Hein, R.; Schwaiblmair, M.; Degenkolb, B.; Krombach, F.; Fruhmann, G. 1995: Pulmonary manifestations of systemic scleroderma: pathophysiologic and clinical significance of the activation of lung fibroblasts Pneumologie 49(4): 266-272
Gluck, E.; Humerfelt, S. 1957: Visceral manifestations of scleroderma; patho-morphologic and clinical study of three cases, verified by autopsy Annales d'Anatomie Pathologique 2(4): 529-547
Parma-Benfenati, S.; Ferreira, P.A.; Fugazzotto, P.A.; Calura, G.; Berdichevsky, M.; Ruben, M.P. 1986: Progressive systemic sclerosis (scleroderma): oral-mucosal changes General Dentistry 34(2): 107-112
Ferreira, L.; Kessler, H.P. 2009: Oral and maxillofacial pathology case of the month. Scleroderma Texas Dental Journal 126(7): 626 638-9
Holmes, H.; Arendorf, T. 1999: Are the oral manifestations associated with HIV infection really relevant to the practising South African dentist? a comparative analysis of oral HIV studies in South Africa Sadj: Journal of the South African Dental Association 54(12): 631-635
Ishikawa, H.; Suzuki, S.; Horiuchi, R.; Sato, H. 1975: An approach to experimental scleroderma, using urinary glycosaminoglycans from patients with systemic scleroderma Acta Dermato-Venereologica 55(2): 97-107
De la Espriella, J.; Crickx, B. 1991: Scleroderma and environment. I. Scleroderma and sclerodermiform states induced by silica and chemical agents or drugs Annales de Dermatologie et de Venereologie 118(12): 948-953
Giordano, M.; Valenti, G. 1986: Linear scleroderma plus systemic sclerosis sine scleroderma plus neuromyopathy of one upper limb: a new entity? Journal of Rheumatology 13(3): 656-657
Pope, J.E.; Bellamy, N. 1995: Sample size calculations in scleroderma: a rational approach to choosing outcome measurements in scleroderma trials Clinical and Investigative Medicine 18(1): 1-10
Madsen, K.L.; Hansen, A.; Halberg, P.; Ullman, S. 2014: Development of scleroderma renal crisis in a patient with undiagnosed scleroderma Ugeskrift for Laeger 176(25a)
Jablonska, S.; Blaszczyk, M. 1999: Scleromyxedema is a scleroderma-like disorder and not a coexistance of scleroderma with papular mucinosis European Journal of Dermatology: Ejd 9(7): 551-554
Black, C.M. 1994: Prognosis and management of scleroderma and scleroderma-like disorders in children Clinical and Experimental Rheumatology 12(Suppl 10): S75-S81
Haustein, U.F.; Ziegler, V. 1986: Scleroderma and scleroderma-like diseases caused by environmental pollutants Dermatosen in Beruf und Umwelt. Occupation and Environment 34(3): 61-67